Calibrate and Withings Study Reveals Enhanced GLP-1 Weight Loss with Wraparound Care
A two-year real-world study conducted by Calibrate Health and Withings Health Solutions indicates that combining GLP-1 weight loss medications with comprehensive wraparound clinical care and behavior change support significantly improves weight loss outcomes. The study, which followed 4,961 U.S. adults, found that Calibrate members, who received integrated obesity care, lost 17.3% of their starting weight at two years, compared to 10.7% for a GLP-1-only group. This represents a more than 60% relative difference. Calibrate's program includes physician-led personalized care, medication optimization, one-to-one coaching focusing on nutrition, activity, sleep, and mindset, and continuous monitoring using Withings devices. The findings suggest that treating obesity as a chronic disease requiring ongoing support, rather than just medication, leads to more effective and sustained weight loss.